He, JC, Alhamwe, BA, Sabroso, S, Carrato, A, Hidalgo, M, Molero, X, Iglesias, M, Perea, J, Farré, A, Tardón, A, Dominguez-Muñoz, E, Barberà, V, Muñoz-Bellvís, L, Löhr, M, Greenhalf, W, O'Rorke, M, Gress, T, Crnogorac-Jurcevic, T, Gayà, A, Langtry, A, Kleeff, J, Lawlor, R, Real, FX, Renz, H, Malats, N, PanGenEU Study Investigators. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk. INTERNATIONAL JOURNAL OF CANCER. 2025; 157(3)DOI:10.1002/ijc.35397. PMID:40098454. IF:4.700(Q1/3D).

Querol, CB, Canyelles, M, Santos, D, Martínez, J, Mercer, A, Zhao, Q, Rotllan, N, Núñez, E, Vázquez, J, Maspoch, D, Cano-Sarabia, M, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).

Borràs, C, Canyelles, M, Santos, D, Rotllan, N, Núñez, E, Vàzquez, J, Maspoch, D, Cano-Sarabia, M, Zhao, Q, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4. JOURNAL OF LIPID RESEARCH. 2025; 66(8)DOI:10.1016/j.jlr.2025.100865. PMID:40701521. IF:4.100(Q2/4D).

Dols-Icardo, O, Reus, LM, Ramirez, A. Genetic architecture of FTLD-TDP pathological subtypes. TRENDS IN NEUROSCIENCES. 2025; 48(8)DOI:10.1016/j.tins.2025.06.005. PMID:40610249. IF:15.100(Q1/1D).